Pooled IPD from 18 trials (3,430 early TNBC patients with pCR): neoadjuvant ICI plus chemotherapy vs chemotherapy alone improved EFS (HR 0.67) but not OS; platinum and anthracycline use made no significant difference, nor did adjuvant ICI after pCR.
Meta-analysisn = 3,430
Ravani et al. Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?